Simultaneously, EMMPRIN expression on CD8+ tumor-infiltrating lymphocytes is significantly elevated, which cooperates with other receptors to negatively regulate antitumor immune responses and facilitate tumor-immune escape, whereas EMMPRIN deficiency can inhibit tumor growth and enhance the effector function of T cells (Chen Y. et al., 2021). This evidence concerns the gene CD8A and neoplasm.